Survival trends over 20 years in patients with advanced cholangiocarcinoma: Results from a national retrospective analysis of 922 cases in Italy.

Front Oncol · 2023 · PMC10113474 · PMID 37091141

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might be significantno p-value reported

Thus, we conclude that, even if the benefits of second-line therapy are limited among unselected patients in the real-world practice, they might be significant in some subgroups of patients ( 22 , 23 ).

also in 2,457 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.